HK2 and central nervous system cancer: In contrast to the level of HK2 in normal brains and low-grade gliomas, HK2 expression is increased in GBM tumours and is correlated with worse overall survival in patients with this disease [5].Recently, deregulated HK2 expression was also found to play a role in the pathogenesis of OSCC [8].